Vimarsana
Biggest News Aggregation in the World

Page 5 - Anders Ullman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders Ullman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Ullman Today - Breaking & Trending Today

Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia - Vimarsana News

Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia

Published: November 10, 2022

/PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret® (anakinra)...

Source: prnewswire.com
Related Topics:
United StatesAnders UllmanEvangelosj Giamarellos BourboulisAssistance CenterWorld Health OrganizationDrug AdministrationSobi Investor Relations TeamInformation ExchangeHellenic Institute For The Study Of SepsisHead Of Research DevelopmentEmergency Use AuthorisationChief Medical OfficerNature MedicineGuided Anakinra TreatmentSevere Respiratory FailureHellenic InstituteEmergency Task ForceOrgan Failure AssessmentFamilial MediterraneanSystemic Juvenile Idiopathic ArthritisAdult Onset StillCytokine Storm Is VitalTissue Specific InflammationInnate ImmunNorth America
Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia (1) - Vimarsana News

Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia (1)

Published: November 10, 2022

STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration has...

Source: europapress.es
Related Topics:
United StatesAnders UllmanEvangelosj Giamarellos BourboulisPrnewswire SobiAssistance CenterWorld Health OrganizationDrug AdministrationSobi Investor Relations TeamInformation ExchangeHellenic Institute For The Study Of SepsisHead Of Research DevelopmentEmergency Use AuthorisationChief Medical OfficerNature MedicineGuided Anakinra TreatmentSevere Respiratory FailureProfessor EvangelosHellenic InstituteEmergency Task ForceOrgan Failure AssessmentFamilial MediterraneanSystemic Juvenile Idiopathic ArthritisAdult Onset StillCytokine Storm Is VitalTissue Specific Inflammation
Swedish Orphan Biovitrum AB: Kineret authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia - Vimarsana News

Swedish Orphan Biovitrum AB: Kineret authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia

Published: November 10, 2022

STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Sobi today announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret (anakinra) for the

Source: finanznachrichten.de
Related Topics:
United StatesAnders UllmanEvangelosj Giamarellos BourboulisPrnewswire SobiAssistance CenterWorld Health OrganizationDrug AdministrationSobi Investor Relations TeamInformation ExchangeHellenic Institute For The Study Of SepsisHead Of Research DevelopmentEmergency Use AuthorisationChief Medical OfficerNature MedicineGuided Anakinra TreatmentSevere Respiratory FailureProfessor EvangelosHellenic InstituteEmergency Task ForceOrgan Failure AssessmentFamilial MediterraneanSystemic Juvenile Idiopathic ArthritisAdult Onset StillCytokine Storm Is VitalTissue Specific Inflammation
ADC Therapeutics SA: ADC Therapeutics and Sobi Announce ZYNLONTA (loncastuximab tesirine) Receives Positive CHMP Opinion in Europe for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma - Vimarsana News

ADC Therapeutics SA: ADC Therapeutics and Sobi Announce ZYNLONTA (loncastuximab tesirine) Receives Positive CHMP Opinion in Europe for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

Published: September 16, 2022

Approval decision expected in 4Q 2022 ADC Therapeutics SA (NYSE: ADCT) and Swedish Orphan Biovitrum AB (Sobi) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European

Source: finanznachrichten.de
Related Topics:
United KingdomUnited StatesNew JerseyCity OfAmanda LoshbaughLausanne BiopMary Ann OndishAnders UllmanJohn RadfordEugenia LitzCompany On TwitterMitsubishi Tanabe Pharma CorporationEuropean CommissionUniversity Of ManchesterDrug AdministrationFoundation Trust In ManchesterExchange CommissionEuropean Medicines AgencyOverland PharmaceuticalsCommittee For Medicinal Products Human UseHead Of Research DevelopmentSwedish Orphan BiovitrumMedicinal ProductsHuman UseAmeet Mallik
Loncastuximab tesirine receives positive CHMP opinion for the treatment of relapsed or refractory diffuse large B-cell lymphoma: Swedish Orphan Biovitrum AB - Vimarsana News

Loncastuximab tesirine receives positive CHMP opinion for the treatment of relapsed or refractory diffuse large B-cell lymphoma: Swedish Orphan Biovitrum AB

Published: September 16, 2022

STOCKHOLM, Sept. 16, 2022 /PRNewswire/ -- Sobi and ADC Therapeutics SA today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted

Source: finanznachrichten.de
Related Topics:
United KingdomUnited StatesNew JerseyCity OfLausanne BiopAnders UllmanJohn RadfordThomas Kudsk LarsenPrnewswire SobiCompany On TwitterEuropean CommissionUniversity Of ManchesterDrug AdministrationSobi Investor Relations TeamFoundation Trust In ManchesterEuropean Medicines AgencyCommittee For Medicinal Products Human UseHead Of Research DevelopmentMedicinal ProductsHuman UseChief Medical OfficerAmeet MallikChief Executive OfficerMedical OncologySan Francisco Bay Area